Erasca (ERAS) Current Assets (2020 - 2026)
Erasca (ERAS) reported Current Assets of $253.8 million for Q1 2026, down 19.34% on a YoY basis from $314.6 million in Q1 2025, and down 11.34% quarter-over-quarter from $286.2 million in Q4 2025.
Erasca (ERAS) Current Assets (2020 - 2026) Analysis & Trends
Erasca has reported Current Assets for 7 years, with the latest figure at $253.8 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 19.34% year-over-year to $253.8 million; the trailing twelve-month figure through Mar 2026 stood at $253.8 million (down 19.34% YoY), and the FY2025 full-year result was $286.2 million, down 7.3% from the prior year.
- Current Assets for Q1 2026 stood at $253.8 million, down from $286.2 million in the prior quarter.
- The five-year high for Current Assets was $444.5 million in Q4 2022, with the low at $253.8 million in Q1 2026.
- Historically, Current Assets has averaged $339.5 million across 5 years, with a median of $320.7 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets soared 93.33% — and 2023, when it decreased 27.86%.
- Erasca's Current Assets stood at $444.5 million in 2022, then declined by 27.86% to $320.7 million in 2023, then dropped by 3.71% to $308.8 million in 2024, then retreated by 7.3% to $286.2 million in 2025, then fell by 11.34% to $253.8 million in 2026.
- The last three Current Assets figures came in at $253.8 million (Q1 2026), $286.2 million (Q4 2025), and $299.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 253.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.78 Mn |
| Dec 31, 2025 | 286.24 Mn |
| Sep 30, 2025 | 299.93 Mn |
| Jun 30, 2025 | 310.66 Mn |
| Mar 31, 2025 | 314.62 Mn |
| Dec 31, 2024 | 308.79 Mn |
| Sep 30, 2024 | 330.17 Mn |
| Jun 30, 2024 | 418.01 Mn |
| Mar 31, 2024 | 306.62 Mn |
| Dec 31, 2023 | 320.68 Mn |
| Sep 30, 2023 | 305.97 Mn |
| Jun 30, 2023 | 323.85 Mn |
| Mar 31, 2023 | 397.88 Mn |
| Dec 31, 2022 | 444.50 Mn |
| Sep 30, 2022 | 365.75 Mn |
| Jun 30, 2022 | 381.42 Mn |
| Mar 31, 2022 | 403.37 Mn |
| Dec 31, 2021 | 420.02 Mn |
| Sep 30, 2021 | 492.31 Mn |
| Jun 30, 2021 | 197.29 Mn |